Approach to the Older Patient with Acute Myeloid Leukemia

Document Type

Article

Publication Date

11-1-2023

Publication Title

Current oncology reports

Abstract

PURPOSE OF REVIEW: This study aims to review the challenges of treating AML in older patients, the spectrum of genomic aberrancies in this cohort, and discuss treatment options for newly diagnosed AML in this patient population.

RECENT FINDINGS: Greater understanding of biological underpinnings of AML and availability of newer, effective, targeted therapies have allowed us to move away from intensification of chemotherapy, to prioritize better tolerability while still maintaining efficacy. Increasing knowledge of the genomic complexity and adverse karyotypes in older AML patients drives the need for ongoing investigations of targeted and lower-intensity therapies in the frontline, relapsed/refractory setting, and post-remission.

Medical Subject Headings

Humans; Aged; Leukemia, Myeloid, Acute; Antineoplastic Combined Chemotherapy Protocols

PubMed ID

37688738

ePublication

ePub ahead of print

Volume

25

Issue

11

First Page

1203

Last Page

1211

Share

COinS